Announcements Trials
Browse Landscape

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Interventional 184Observational 4Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Myeloid 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Myeloid, Chronic-Phase 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × Dasatinib × Clear all
NCT03885830 2023-01-11

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

UNC Lineberger Comprehensive Cancer Center

Completed
45 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT03318770 2022-10-12

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adulto

Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02421926 2019-07-08

IDEAL-E

Asan Medical Center

Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03331211 2017-11-08

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Nanfang Hospital, Southern Medical University

Unknown
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡